Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

3.00USD
21 Aug 2018
Change (% chg)

-- (--)
Prev Close
$3.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
258,538
52-wk High
$6.66
52-wk Low
$2.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.124
Mar '18 0.15 -0.150
FY 2017 Dec '17 1.60 -0.130
Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.88 2.00 0.00 1.27
Quarter Ending Dec-18 5 0.88 2.00 0.00 1.27
Year Ending Dec-18 4 0.62 1.60 0.15 5.93
Year Ending Dec-19 4 3.95 6.00 0.58 62.53
Earnings (per share)
Quarter Ending Sep-18 5 -0.12 -0.07 -0.14 -0.15
Quarter Ending Dec-18 5 -0.12 -0.08 -0.14 -0.15
Year Ending Dec-18 5 -0.50 -0.42 -0.55 -0.59
Year Ending Dec-19 5 -0.37 -0.22 -0.50 -0.43
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.69 32.76
P/E High - Last 5 Yrs. -- 300.66 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 1.54 0.93 0.89
Price to Sales (TTM) 139.32 114.99 5.75
Price to Book (MRQ) -- 15.52 5.00
Price to Tangible Book (MRQ) 12.72 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 54.51 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 411.56 8.01
Sales (TTM) vs TTM 1 Yr. Ago -14.29 80.51 5.64
Sales - 5 Yr. Growth Rate 59.39 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 39.85 10.66
Capital Spending - 5 Yr. Growth Rate -13.77 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 7.83 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.36 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -600.69 10.68
Operating Margin (TTM) -767.01 -759.79 4.32
Operating Margin - 5 Yr. Avg. -3,450.43 -621.72 6.11
Pre-Tax Margin (TTM) -789.28 -733.64 5.18
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -627.42 6.51
Net Profit Margin (TTM) -789.28 -735.01 1.48
Net Profit Margin - 5 Yr. Avg. -3,320.66 -630.47 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 23,231,105 860,375,625
Net Income/Employee (TTM) -1,400,750 3,144,294 101,207,245
Receivable Turnover (TTM) 216.58 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.05 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -0.16 11.13
Return on Assets - 5 Yr. Avg. -101.96 3.51 12.40
Return on Investment (TTM) -45.27 1.78 14.61
Return on Investment - 5 Yr. Avg. -120.26 2.56 16.13
Return on Equity (TTM) -- 3.28 16.33
Return on Equity - 5 Yr. Avg. -220.88 3.42 17.39
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.56%
# of Holders: 176
Total Shares Held: 57,746,489
3 Mo. Net Change: -1,192,774
# New Positions: 15
# Closed Positions: 19
# Increased Positions: 61
# Reduced Positions: 62
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.